2022-10-14T05:11:01+03:00[Europe/Moscow] en true <p>Pharmacology</p>, <p>Medical pharmacology</p>, <p>Toxicology</p>, <p>Drug</p>, <p>Poison</p>, <p>Toxin</p>, <p>Toxicant</p>, <p>receptor</p>, <p>regulatory receptor</p>, <p>enzyme receptors</p>, <p>transport receptors</p>, <p>structural receptors</p>, <p>positive allosteric modulator</p>, <p>negative allosteric modulator</p>, <p>efficacy</p>, <p>Emax</p>, <p>EC50</p>, <p>Affinity</p>, <p>Kd</p>, <p>Bmax</p>, <p>Coupling</p>, <p>quantal dosing</p>, <p>therapeutic index</p>, <p>nuclear receptor</p>, <p>Cytokine receptor</p> flashcards
BMS1 Pharmacology

BMS1 Pharmacology

  • Pharmacology

    study of substances that interact with living systems through chemical processes

  • Medical pharmacology

    division of science involving using substances to prevent, diagnose, and/or treat disease

  • Toxicology

    study of adverse effects of substances on living systems

  • Drug

    a substance that affects a biological system in a potentially useful way

  • Poison

    any substance capable of producing a harmful effect

  • Toxin

    a naturally - occurring poison

  • Toxicant

    synthetic poison

  • receptor

    the component of a cell or organism that interacts with a drug and leads to the observed effects

  • regulatory receptor

    type of drug receptor responsible for mediating the action of endogenous chemical signals

  • enzyme receptors

    type of drug receptor that mediates chemical reactions/structural conversions

  • transport receptors

    type of drug receptor that moves things, often across membranes

  • structural receptors

    type of drug receptor that provides tissue or cellular structure

  • positive allosteric modulator

    ligand that binds outside the orthosteric site and subsequently increases the affinity of an agonist for that receptor

  • negative allosteric modulator

    ligand that binds outside the orthosteric site and subsequently decreases the affinity of an agonist for that receptor

  • efficacy

    measure of the maximal effect produced by a drug-receptor interaction at plateau

  • Emax

    descriptor of efficacy (measure of max effect produced at plateau)

  • EC50

    concentration of drug required to produce an effect of a given intensity (eg EC50)

  • Affinity

    measure of the strength and probability that a drug will bind an available receptor

  • Kd

    equilibrium dissociation constant - concentration of drug where 1/2 receptors are occupied

  • Bmax

    maximal amount of receptors bound by a drug at plateau

  • Coupling

    process tying drug binding to the end effect observed

  • quantal dosing

    all or none response used to indicate efficacious doses

  • therapeutic index

    measure or the ratio between a toxic and efficacious doses

  • nuclear receptor

    intracellular receptors that regulate gene transcription after activation by a lipid-soluble agonist

  • Cytokine receptor

    transmembrane protein with an extracellular ligand binding domain and an intracellular domain that does not have intrinsic kinase activity, but interacts with kinases